None
Quote | First Trust Amex Biotech Index Fund (NYSE:FBT)
Last: | $146.26 |
---|---|
Change Percent: | 2.33% |
Open: | $143.82 |
Close: | $142.93 |
High: | $146.59 |
Low: | $143.82 |
Volume: | 14,175 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | First Trust Amex Biotech Index Fund (NYSE:FBT)
2024-04-21 08:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-16 10:30:00 ET Summary The rise in rates last week pushed the 10-year to its highest level since the peak at 5% in October of last year. Gold has been setting new highs, trading above $2400 at one point on Friday before succumbing to some profit taking. Year-to-date, t...
Message Board Posts | First Trust Amex Biotech Index Fund (NYSE:FBT)
Subject | By | Source | When |
---|---|---|---|
wow, this is a bricksnick house! | Fibanotch | investorshub | 08/21/2018 4:57:22 PM |
News, Short Squeeze, Breakout and More Instantly...
First Trust Amex Biotech Index Fund Company Name:
FBT Stock Symbol:
NYSE Market:
2024-04-21 08:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-12 09:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-09 06:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...